|
Volumn 13, Issue 4, 2001, Pages 339-340
|
'High-alert' medications and patient safety
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
HEPARIN;
HYDROMORPHONE;
INSULIN;
MORPHINE;
NARCOTIC AGENT;
OPIATE;
POTASSIUM CHLORIDE;
POTASSIUM DIHYDROGEN PHOSPHATE;
SODIUM CHLORIDE;
ACCREDITATION;
ALERTNESS;
ARTICLE;
CLINICAL PRACTICE;
CONCENTRATION (PARAMETERS);
DEATH;
DRUG ADMINISTRATION ROUTE;
DRUG LABELING;
DRUG STORAGE;
DRUG THERAPY;
DRUG USE;
GOOD CLINICAL PRACTICE;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HUMAN;
INJURY;
NEGLIGENCE;
PATIENT CARE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
SAFETY;
TIME;
ANTICOAGULANTS;
HEPARIN;
HUMANS;
INSULIN;
JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS;
MEDICATION ERRORS;
MEDICATION SYSTEMS, HOSPITAL;
NARCOTICS;
POTASSIUM;
SAFETY MANAGEMENT;
SENTINEL SURVEILLANCE;
SODIUM CHLORIDE;
UNITED STATES;
|
EID: 0034869032
PISSN: 13534505
EISSN: None
Source Type: Journal
DOI: 10.1093/intqhc/13.4.339 Document Type: Article |
Times cited : (55)
|
References (2)
|